BusinessFilament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel DiseaseBy Nasdaq OMXJan 31, 2018, 1:01 PM UTC